Weight A Minute! Do the weight loss drugs keep working?

In this Tad bit, Tadd E. Lane discusses the weight loss drug Tizepatide, also known as Monjaro or ZepBound. He reviews a study published in the Journal of American Medical Association that focuses on the long-term effects of the drug on weight loss maintenance. The study found that participants who continued to use Tizepatide maintained at least 80% of their weight loss over a period of 88 weeks. However, Tadd emphasizes that medication alone is not the answer to weight loss and that a calorie deficit and physical activity are still crucial. He also mentions the gastrointestinal side effects of Tizepatide and the potential challenges of affordability and insurance coverage.